Acurx Pharmaceuticals, Inc.

10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Director or officer change; Other events Mar 9, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Amended charter or bylaws Sep 22, 2025 8-K Shareholder vote results Sep 19, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jul 31, 2025 8-K Shareholder vote results Jul 17, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 20, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Entered a material agreement; Unregistered sale of equity May 8, 2025 8-K Delisting notice or listing-rule failure Mar 28, 2025 8-K Results of operations (earnings release) Mar 18, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 10, 2025 8-K Delisting notice or listing-rule failure Feb 26, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 7, 2025 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Shareholder vote results Jun 17, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) Mar 18, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Entered a material agreement Nov 15, 2023 8-K Results of operations (earnings release) Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Other events Nov 3, 2023 8-K Other events Oct 2, 2023 8-K Results of operations (earnings release) Aug 14, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Amended charter or bylaws; Shareholder vote results Jun 20, 2023 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders May 17, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Results of operations (earnings release); Other events Mar 16, 2023